The Lancet Microbe

The role of the vaginal microbiota, sexually transmitted infections, ureaplasmas, and Mycoplasma hominis in pregnancy loss: a prospective study in pregnant women in Denmark In this cohort study, evaluation of the vaginal microbiota highlighted differences in Lactobacillus spp between women with ongoing pregnancy and those experiencing pregnancy loss. Bacterial vaginosis-...

NEW ONLINE. An Article reports findings of a cohort study from Denmark looking at the role of the vaginal microbiota, sexually transmitted infections, ureaplasmas, and Mycoplasma hominis in pregnancy loss www.thelancet.com/journals/lan...
A linked Comment discusses the study's implications.

Sustainable HIV prevention in Africa Despite more than four decades of progress, HIV remains a global health challenge, with 1·3 million new infections a year. The six-paper Series on Sustainable HIV Prevention in Africa argues that epid...

📢 Out today! A new Series, jointly with The Lancet HIV, on sustainable #HIV prevention in Africa
www.thelancet.com/series-do/su...

The cover of the fifth issue of The Lancet Primary Care, featuring a photo of two older women, one in a hijab, looking at a smart phone.

Our fifth issue is now live and free to read for all!🎉

➡️Explore and download the issue on our journal homepage: hubs.li/Q03yqV6c0

Best practice guidelines for viral hepatitis service delivery in prisons Viral hepatitis constitutes a major health burden among people living in prison globally. There is poor access to prison-based viral hepatitis services, and people living in prison are rarely prioriti...

New Review

Best practice guidelines for viral hepatitis service delivery in prisons

www.thelancet.com/journals/lan...

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial In people with advanced HIV disease, bictegravir, emtricitabine, and tenofovir alafenamide was shown to be non-inferior to darunavir, cobicistat, emtricitabine, and tenofovir alafenamide and resulted ...

New Research

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial

www.thelancet.com/journals/lan...

New personal view article

The concept of external quality assessment super challenges with special consideration of their importance during pandemics

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #EQA #OpenAccess #OA

New research article

Efficacy, immunogenicity, and safety of the live attenuated nasal #pertussis #vaccine, BPZE1, in the UK

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #Bordetella #CHIM #OpenAccess #OA

New issue is live!🙌

Read about smoking & #vaping in #Oceania, pediatric #MASLD in #China, smartphone-based #CBT in #Japan, #Malaria microscopy in #Indonesia & more!

🖋️ Editorial: #Diabetes underdiagnosis
🎨 Cover by Van-Mai CAO-LORMEAU
🔗 tinyurl.com/4haau2s3

#MedSky #IDSky #PsySky

The cover of the December 2025 issue of The Lancet Global Health, featuring a colourful image of an informal settlement in India, with people sitting on the ground outside, talking. Image credit: Adam Cohn.

Our December issue is now live! www.thelancet.com/journals/lan...
Featuring:
👉🏻 The global burden of sepsis
www.thelancet.com/journals/lan...
👉🏻 Violence against women in informal settlements
www.thelancet.com/journals/lan...
👉🏻 Equitable RSV prevention in infants
www.thelancet.com/journals/lan...

Our latest editorial is now online in advance of our upcoming December issue

Neglected tropical diseases: golden age of elimination?

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #NTD #OpenAccess #OA

New research article

Macrolide-resistant #Mycoplasma pneumoniae resurgence in Chinese children in 2023: a longitudinal, cross-sectional, genomic epidemiology study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #AMR #OpenAccess #OA

Chikungunya in Brazil: vaccination strategies informed by mathematical modelling The licensing of the first chikungunya virus (CHIKV) vaccine in Brazil marked a pivotal moment in the global fight against this expanding arbovirus. Over the past two decades, CHIKV has emerged as one...

New Comment

Chikungunya in Brazil: vaccination strategies informed by mathematical modelling

www.thelancet.com/journals/lan...

The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling study Despite widespread circulation, most of Brazil remains susceptible to infection. CHIKV vaccination has the potential to substantially reduce disease burden.

New Research

The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling study

www.thelancet.com/journals/lan...

Cover of The Lancet's Nov 29, 2025 Cover. Quote reads: "The decision not to fully support the Global Fund—the most successful multilateral health programme in history—risks the health of millions of people and prompts serious questions for the organisation."

The Global Fund has fallen short of its $18 billion target, risking the progress made against AIDS, TB, and malaria.

Our latest Editorial discusses the challenges and opportunities in shaping the future of global health investment.

Read this & more: spkl.io/63321A5zXh

New research article

#HIV drug resistance during #antiretroviral therapy scale-up in Uganda, 2012–19: a population-based, longitudinal study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #AMR #OpenAccess #OA

New research article

Transmission of extended spectrum β-lactamase-producing Escherichia coli and antimicrobial resistance gene flow across #OneHealth compartments in eastern Africa

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #AMR #OpenAccess #OA

New personal view article

Tackling #vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #OpenAccess #OA

📢 November issue now online featuring #PalliativeCare, #Endometriosis, #Stroke, #DiabeticNeuropathy, #Melanoma, #mpox, and much more with our editorial on air pollution and child health

…all available #free, #OpenAccess❗️

Read more here: www.thelancet.com/issue/S2589-...

Attribution: Getty
#MedSky

Infographic outlining the enormous, growing, and unevenly distributed threat to global health that antimicrobial resistance poses.

An infographic on existing interventions that can have a significant impact on AMR in LMICs: Aligning infection & prevention control, access to WASH services, and high-priority paediatric vaccines.

"The problem of [antimicrobial resistance] has been seen as either not urgent or too difficult to solve. Neither is true."

A Series spotlights this global issue & how existing infection prevention methods could save 750,000 lives a year: spkl.io/63323AdRFP #WorldAMRAwarenessWeek

Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study The 2023–2024 M pneumoniae epidemic in France resulted in a substantial paediatric hospitalisation burden. Although severe cases were uncommon, children older than 11 years, those with asthma, other c...

New Research

Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study

www.thelancet.com/journals/lan...

Read our December issue!

Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.

www.thelancet.com/issue/S1473-...

New research article

Direct and indirect protection against #scabies through #ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #MDA #OpenAccess #OA

Figure: Emerging therapies for tackling AMR. Copyright: The Author(s). Published by Elsevier Ltd. CC BY 4.0.

Antimicrobial resistance (AMR) is a serious threat to health, with approximately 5 million associated deaths in 2019 alone.

A Review in @lancetmicrobe.bsky.social highlights the urgent need to address the ongoing global effects of AMR: spkl.io/63322AdB5g #WorldAMRAwarenessWeek

The next decade in AMR: getting the basics right Nov 18–24, 2025, marks the 10th edition of World AMR Awareness Week, an annual campaign led by WHO with the goal to increase awareness of global antimicrobial resistance (AMR) and to encourage best pr...

"The UK’s inability to maintain sustained, transparent leadership on #AMR undermines global efforts and highlights the urgent need for governments worldwide to prioritise long-term, accountable strategies."

www.thelancet.com/journals/lan...

Antimicrobial resistance: a concise update Antimicrobial resistance (AMR) is a serious threat to global public health, with approximately 5 million deaths associated with bacterial AMR in 2019. Tackling AMR requires a multifaceted and cohesive...

Reflection as we begin #WorldAntimicrobialAwarenessWeek #WAAW

🔴 #AMR is a growing global emergency

🔴 Solutions must go beyond prescribing #diagnostics #access #prevention

🔴 No one is safe until everyone is safe, solutions must reach all

www.thelancet.com/journals/lan...
#episky #microsky @msf.ca

Exciting @thelancet.com podcast: Genomic surveillance of #Mpox in Central African Republic. With Dr Christian Noël Malaka, Dr Livia Patrono & Rebecca Barksby (@lancetmicrobe.bsky.social).

Listen: podcasts.apple.com/gb/podcast/c...

Article: www.thelancet.com/journals/lan...

I'm delighted to share our latest publication in The Lancet Microbe on the development of a predictive biomarker for Adult T-cell leukemia (ATL) an aggressive malignancy induced by human T-cell leukemia virus (HTLV-1).
www.thelancet.com/journals/lan...

@lancetmicrobe.bsky.social

Cover of the November issue of The Lancet Microbe

Our November issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza

#IDSky #ClinMicro #OA

New review article

P2Y12 inhibitors in #Staphylococcus aureus #bacteraemia: current evidence and clinical implications

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #bacteremia #OpenAccess #OA

Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiori... Voriconazole was not superior to itraconazole for treating chronic pulmonary aspergillosis and was associated with a significantly higher incidence of adverse events. Our findings support the continue...

New Research

Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial

www.thelancet.com/journals/lan...